SALIX PHARMACEUTICALS LTD 4
4 · SALIX PHARMACEUTICALS LTD · Filed Dec 23, 2014
Insider Transaction Report
Form 4
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Option to Buy Common Stock
2014-12-22−44,000→ 0 totalExercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying) - Exercise/Conversion
Common Stock
2014-12-22$17.63/sh+44,000$775,720→ 703,838.2 total
Holdings
- 400,000(indirect: By GRAT)
Common Stock
Footnotes (2)
- [F1]The Reporting Person exercised this option on December 22, 2014 and held the resulting 44,000 shares of the Issuer's common stock.
- [F2]Option is 100% vested.